[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 5, 1903


JAMA. 1903;XLI(10):611. doi:10.1001/jama.1903.02490290023009

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The Journal has received through a correspondent a copy of a circular letter sent out by a drug manufacturing firm, which we do not care to advertise here by a name, proposing to allow physicians 10 per cent, commission on the refills of prescriptions of the firm's preparations. They argue that the physician is entitled to something on the refilling of his prescriptions, but, under the usual practice, he alone of the trio—manufacturer, retailer and prescriber—does not profit. It is easy to see how the manufacturer hopes to increase his profits if the physician will only co-operate. The professional aspect of the transaction is another thing. No matter how excellent the products of this firm may be, and we know nothing about them, no ethical physician would accept a commission for prescriptions and much less we should say for their unauthorized repetition, as is implied in the circular letter referred

First Page Preview View Large
First page PDF preview
First page PDF preview